EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Metoprolol Population Pharmacokinetics in Older Chinese Patients With CKM Syndrome: Joint Effects of rs1065852 and CKM 2 S 2 ‐ BAG Score on Clearance

Haodi Chai iD, Jie En Valerie Sia iD, Dingyuan Hu iD, Yunshu Jia, Suiyuan Hu iD, Xinyi Wu, Dongyang Liu iD, Xuan Lai iD, Cheng Cui iD

Clinical and Translational Science · 2026-08 · 19 (8)

DOI: 10.1111/cts.70677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 24.07.2026. Verfasst von Haodi Chai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Geriatrics Department, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Metoprolol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Older adults are vulnerable to adverse drug reactions due to multimorbidity, frailty and polypharmacy. In those with cardiovascular‐kidney‐metabolic (CKM) syndrome, CKM‐related multi‐organ burden may further alter drug disposition and elevate risk. Metoprolol exposure varies widely among individuals, and higher plasma concentrations have been associated with falls in prior studies. We aimed to develop a population pharmacokinetic (PopPK) model of metoprolol in older Chinese patients with CKM syndrome using real‐world data, identify key covariates affecting clearance, and perform model‐based dose simulations. The PopPK analysis included sparse real‐world data from 42 older adults (60–93 years) receiving immediate‐release metoprolol tartrate. Candidate covariates included demographics, genetic polymorphism, laboratory variables, comorbidities, frailty phenotype, SARC‐F score, age‐adjusted Charlson Comorbidity Index, CKM stage and CKM 2 S 2 ‐BAG score. Model‐based simulations were conducted across predefined genotype‐ and disease‐burden strata to evaluate dosing scenarios against literature‐based thresholds. Metoprolol pharmacokinetics were adequately described by a one‐compartment model with first‐order absorption and elimination. The rs1065852 T/T genotype and a high CKM 2 S 2 ‐BAG score (> 11) were associated with lower apparent clearance ( CL/F ), resulting in approximately 32% and 30% reductions in CL/F , respectively, and reduced interindividual variability in CL/F from 46.9% to 39.9%. Simulations identified subgroup‐specific dosing regimens that maintained steady‐state trough concentrations within a literature‐derived range. In older Chinese patients with CKM syndrome, rs1065852 and CKM‐related burden influenced metoprolol clearance and accounted for a considerable part of the observed variability between individuals. This study provides a model‐informed framework for exposure‐threshold‐based dose stratification. Prospective validation with clinical outcomes and comprehensive CYP2D6 genotyping is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMetoprololAgedAged, 80 and overFemaleHumansMaleMiddle AgedChinaModels, BiologicalPolymorphism, Single NucleotideEast Asian People

Stichwörter der Autor:innen

CKM syndromeCYP2D6advanced ageindividualized dosingmetoprololpopulation pharmacokinetic

Substanzen

Metoprolol

Autor:innen und Institutionen

  • Geriatrics Department, Peking University Third Hospital, Beijing, China.
  • Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, China.
  • Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University Third Hospital, Beijing, China.

ORCID-Profile: Haodi Chai, Jie En Valerie Sia, Dingyuan Hu, Suiyuan Hu, Dongyang Liu, Xuan Lai, Cheng Cui

Zitieren

APA

Chai, H., Sia, J. E. V., Hu, D., Jia, Y., Hu, S., Wu, X., Liu, D., Lai, X., & Cui, C. (2026). Metoprolol Population Pharmacokinetics in Older Chinese Patients With CKM Syndrome: Joint Effects of rs1065852 and CKM 2 S 2 ‐ BAG Score on Clearance. Clinical and Translational Science, 19(8). https://doi.org/10.1111/cts.70677

Vancouver

Chai H, Sia JEV, Hu D, Jia Y, Hu S, Wu X, et al. Metoprolol Population Pharmacokinetics in Older Chinese Patients With CKM Syndrome: Joint Effects of rs1065852 and CKM 2 S 2 ‐ BAG Score on Clearance. Clinical and Translational Science. 2026;19(8). doi:10.1111/cts.70677

BibTeX
@article{Chai2026,
  author = {Chai, Haodi and Sia, Jie En Valerie and Hu, Dingyuan and Jia, Yunshu and Hu, Suiyuan and Wu, Xinyi and Liu, Dongyang and Lai, Xuan and Cui, Cheng},
  title = {Metoprolol Population Pharmacokinetics in Older Chinese Patients With CKM Syndrome: Joint Effects of rs1065852 and CKM 2 S 2 ‐ BAG Score on Clearance},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {8},
  doi = {10.1111/cts.70677}
}
Kostenlos starten →